imugene expands car t-cell and oncolytic virotherapy trials in australia and the us
Published 2 days ago • 381 plays • Length 5:25Download video MP4
Download video MP3
Similar videos
-
5:25
imugene expands car t-cell and oncolytic virotherapy trials in australia and the us
-
3:58
car t explained
-
4:14
imugene doses first patient in phase 1 oncarlytics iv infusion combination trial
-
43:25
esgct e-seminar: combining oncolytic viruses and car-t therapies
-
4:54
imugene reports promising results in phase 1b trial for azer-cel in dlbcl
-
2:20
the risk of t-cell malignancies associated with car t-cell therapy
-
8:45
what role does autologous haematopoietic stem cell transplant (ahsct) play in ms treatment?
-
3:19
immatics’ clinical tcr bispecifics (tcer®) trials: a patient’s journey
-
3:16
synthesis, preclinical analysis, and first-inhuman phase i imaging of 89zr-dfodaratumumab for cd...
-
3:05
using patient-derived organoids to investigate bispecific t-cell engager immunotherapy in fl
-
1:45
evaluating nivolumab-based therapy to restore t-cell fitness in patients with r/r multiple myeloma
-
0:40
glucose and cells. glucose transporter: how insulin gets glucose into a cell
-
1:47
delivery of oncolytic viruses via mesenchymal stem cells for cancer therapy
-
24:39
iclio webinar: managing immuno-oncology patient expectations
-
17:17
justin o'grady│rapid metagenomic diagnosis of hospital acquired pneumonia
-
1:18
unmet needs in glioblastoma treatment
-
3:15
mcg ambulatory care: new evidence for insulin pumps
-
11:23
incysus enters clinical trial for genetically-modified t cells for treating glioblastoma